Neuronetics, Inc.
NASDAQ:STIM
Overview | Financials
Company Name | Neuronetics, Inc. |
Symbol | STIM |
Currency | USD |
Price | 1.08 |
Market Cap | 32,731,992 |
Dividend Yield | 0% |
52-week-range | 0.664 - 5.07 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Keith J. Sullivan |
Website | https://www.neurostar.com |
An error occurred while fetching data.
About Neuronetics, Inc.
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD